Boston Scientific (BSX) Net Cash Flow (2009 - 2026)
Boston Scientific (BSX) posted quarterly Net Cash Flow of -$892.0 million for Q2 2026, down 395.56% year-over-year from $301.8 million in Q2 2025, and down 77.34% on a QoQ basis from -$503.0 million in Q1 2026.
Boston Scientific (BSX) Net Cash Flow (2009 - 2026) Analysis & Trends
Boston Scientific has reported Net Cash Flow for 18 years, with the latest figure at -$892.0 million in Q2 2026.
- Net Cash Flow for Q2 2026 came in at -$892.0 million, down 395.56% year-over-year; the trailing twelve-month figure through Jun 2026 was $10.0 million (up 100.42% YoY), and the FY2025 annual result was $1.5 billion, up 442.24% from the prior year.
- Net Cash Flow eased to -$892.0 million in Q2 2026, from -$503.0 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $1.4 billion in Q1 2024 and troughed at -$2.0 billion in Q4 2024.
- A 5-year average of -$79.6 million and a median of -$73.5 million in 2022 frame the typical range for Net Cash Flow.
- The widest annual swing landed in 2022, when Net Cash Flow soared 6844.44%; it then slumped 2411.11% in 2024.
- A 5-year view of Net Cash Flow shows it stood at $625.0 million in 2022, then slumped by 112.96% to -$81.0 million in 2023, then slumped by 2411.11% to -$2.0 billion in 2024, then jumped by 132.84% to $668.0 million in 2025, then slumped by 233.53% to -$892.0 million in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were -$892.0 million in Q2 2026, -$503.0 million in Q1 2026, and $668.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | -14.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -892.00 Mn |
| Jun 30, 2026 | -892.00 Mn |
| Mar 31, 2026 | -503.00 Mn |
| Mar 31, 2026 | -503.00 Mn |
| Dec 31, 2025 | 668.00 Mn |
| Dec 31, 2025 | 668.00 Mn |
| Sep 30, 2025 | 737.00 Mn |
| Sep 30, 2025 | 737.00 Mn |
| Jun 30, 2025 | -180.00 Mn |
| Jun 30, 2025 | -180.00 Mn |
| Mar 31, 2025 | 274.00 Mn |
| Mar 31, 2025 | 274.00 Mn |
| Dec 31, 2024 | -2.03 Bn |
| Dec 31, 2024 | -2.03 Bn |
| Sep 30, 2024 | -418.00 Mn |
| Sep 30, 2024 | -418.00 Mn |
| Jun 30, 2024 | 566.00 Mn |
| Jun 30, 2024 | 566.00 Mn |
| Mar 31, 2024 | 1.45 Bn |
| Mar 31, 2024 | 1.45 Bn |